Literature DB >> 8984658

Tumor-killer made; how does it work?

R F Service.   

Abstract

Mesh：

Substances：

Year:  1996        PMID： 8984658     DOI： 10.1126/science.274.5295.2009

Source DB:  PubMed          Journal:  Science        ISSN： 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  4 in total

1.  Desoxyepothilone B is curative against human tumor xenografts that are refractory to paclitaxel.

Authors:  T C Chou; X G Zhang; C R Harris; S D Kuduk; A Balog; K A Savin; J R Bertino; S J Danishefsky
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-22       Impact factor: 11.205

2.  A common pharmacophore for epothilone and taxanes: molecular basis for drug resistance conferred by tubulin mutations in human cancer cells.

Authors:  P Giannakakou; R Gussio; E Nogales; K H Downing; D Zaharevitz; B Bollbuck; G Poy; D Sackett; K C Nicolaou; T Fojo
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-14       Impact factor: 11.205

3.  Desoxyepothilone B: an efficacious microtubule-targeted antitumor agent with a promising in vivo profile relative to epothilone B.

Authors:  T C Chou; X G Zhang; A Balog; D S Su; D Meng; K Savin; J R Bertino; S J Danishefsky
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-04       Impact factor: 11.205

4.  Trial watch: Chemotherapy with immunogenic cell death inducers.

Authors:  Erika Vacchelli; Laura Senovilla; Alexander Eggermont; Wolf Hervé Fridman; Jérôme Galon; Laurence Zitvogel; Guido Kroemer; Lorenzo Galluzzi
Journal:  Oncoimmunology       Date:  2013-03-01       Impact factor: 8.110
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.